Clinical trials
Poor Ovarian Response clinical trials
Below are recruiting poor ovarian response clinical trials, each written for real people, not researchers. We’re tracking 6 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT03560583Recruiting
Metoclopramide for women with poor IVF response
This trial tests metoclopramide, a medicine used for certain stomach and nausea conditions, to see if it can improve outcomes for women who have had poor response to IVF. If you fit the “poor ovarian response” definition, you may be eligible after checking the specific exclusions.
Ashkelon, Ashkelon DistrictAges 18–54 - NCT06645379Recruiting
Platelet-rich plasma for fertility treatments
This trial tests whether injecting platelet-rich plasma (a concentrate from your own blood) into the uterus or ovaries can help women with certain fertility issues, such as damaged uterine lining, scarring, or low egg reserve. It aims to improve pregnancy chances in these challenging cases.
Yiwu, ZhejiangAges 18–50 - NCT05181748RecruitingPhase 2/Phase 3
Platelet-rich plasma into ovaries for low egg response
This trial tests whether injecting your own platelet-rich plasma (PRP) into the ovaries can improve egg production in people who don’t respond well to fertility stimulation. It may help some “poor responders” get more usable eggs for IVF.
Athens, AtticaAges 35–47 - NCT07764133Recruiting
Body scans to predict ovarian cancer treatment response
This study uses whole-body scans to look at how active tumors are in women with suspected ovarian cancer. The goal is to see if these scans can predict how well treatment will work, which may help personalize care.
Knoxville, TennesseeAges 18 years+ - NCT03937661RecruitingPhase 2/Phase 3
Platelet-rich plasma injected into ovaries for poor egg responders
This trial studies whether an injection of your own “platelet-rich” plasma into the ovaries can improve egg production in people who respond poorly to fertility treatment. It targets women with low egg reserve and tries to see if this approach helps them get better results from stimulation.
AthensAges 35–47 - NCT07446608Recruiting
MRI to predict response to dienogest for endometriosis
This study uses MRI scans to see if they can predict how well dienogest, a hormone treatment, will work for endometriosis. If you have endometriosis and haven't used dienogest before, this trial could help find the best treatment for you.
Sejong, Sejong Special Self-Governing CityAges 19–45
Hear when a new Poor Ovarian Response trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for poor ovarian response?
- Yes. Clin2 currently lists 6 recruiting poor ovarian response studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a poor ovarian response trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a poor ovarian response trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.